DreamTec focuses on the research and development of four major innovative biotechnologies, including: genetic engineering, large-scale recombinant protein production technology, 3D biological organ printing technology and stem cell culture technology, etc., and has achieved breakthrough achievements in each field and has achieved a number of exclusive R&D results. The scientific research team has published a number of scientific papers internationally, and has also applied for a number of technological invention patents in Europe, America, China and Hong Kong.